Bank of America’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-26,700
| Closed | -$2.96M | – | 7741 |
|
|
2025
Q3 | $2.96M | Sell |
26,700
-122,800
| -82% | -$14M | ﹤0.01% | 4474 |
|
|
2025
Q2 | $16.6M | Sell |
149,500
-152,000
| -50% | -$16.2M | ﹤0.01% | 2748 |
|
|
2025
Q1 | $33.8M | Sell |
301,500
-10,600
| -3% | -$1.09M | ﹤0.01% | 1938 |
|
|
2024
Q4 | $28.8M | Sell |
312,100
-14,300
| -4% | -$1.29M | ﹤0.01% | 1972 |
|
|
2024
Q3 | $27.4M | Sell |
326,400
-116,100
| -26% | -$8.86M | ﹤0.01% | 2100 |
|
|
2024
Q2 | $30.4M | Sell |
442,500
-100,400
| -18% | -$6.7M | ﹤0.01% | 1851 |
|
|
2024
Q1 | $39.8M | Buy |
542,900
+278,300
| +105% | +$21.4M | ﹤0.01% | 1657 |
|
|
2023
Q4 | $21.4M | Sell |
264,600
-6,300
| -2% | -$490K | ﹤0.01% | 2095 |
|
|
2023
Q3 | $20.3M | Sell |
270,900
-261,100
| -49% | -$20.1M | ﹤0.01% | 2013 |
|
|
2023
Q2 | $41M | Buy |
532,000
+77,500
| +17% | +$6.18M | ﹤0.01% | 1458 |
|
|
2023
Q1 | $37.7M | Sell |
454,500
-200,700
| -31% | -$16.6M | ﹤0.01% | 1580 |
|
|
2022
Q4 | $56.2M | Buy |
655,200
+19,000
| +3% | +$1.5M | 0.01% | 1218 |
|
|
2022
Q3 | $39.2M | Buy |
636,200
+353,400
| +125% | +$22.3M | ﹤0.01% | 1435 |
|
|
2022
Q2 | $17.5M | Sell |
282,800
-143,500
| -34% | -$8.88M | ﹤0.01% | 2135 |
|
|
2022
Q1 | $25.3M | Sell |
426,300
-1,184,900
| -74% | -$75.7M | ﹤0.01% | 1923 |
|
|
2021
Q4 | $117M | Buy |
1,611,200
+597,900
| +59% | +$41.2M | 0.01% | 913 |
|
|
2021
Q3 | $70.8M | Sell |
1,013,300
-244,100
| -19% | -$17.1M | 0.01% | 1142 |
|
|
2021
Q2 | $86.6M | Buy |
1,257,400
+391,800
| +45% | +$26.2M | 0.01% | 1024 |
|
|
2021
Q1 | $55.9M | Buy |
865,600
+511,100
| +144% | +$33M | 0.01% | 1215 |
|
|
2020
Q4 | $20.7M | Sell |
354,500
-168,300
| -32% | -$10.2M | ﹤0.01% | 1857 |
|
|
2020
Q3 | $33M | Buy |
522,800
+263,400
| +102% | +$18.3M | ﹤0.01% | 1336 |
|
|
2020
Q2 | $20M | Sell |
259,400
-123,600
| -32% | -$9.47M | ﹤0.01% | 1624 |
|
|
2020
Q1 | $28.6M | Sell |
383,000
-347,200
| -48% | -$24M | 0.01% | 1269 |
|
|
2019
Q4 | $47.4M | Buy |
730,200
+610,000
| +507% | +$39.7M | 0.01% | 1214 |
|
|
2019
Q3 | $7.62M | Sell |
120,200
-208,500
| -63% | -$13.6M | ﹤0.01% | 2796 |
|
|
2019
Q2 | $22.2M | Buy |
328,700
+102,600
| +45% | +$6.75M | ﹤0.01% | 1779 |
|
|
2019
Q1 | $14.7M | Sell |
226,100
-250,900
| -53% | -$16.7M | ﹤0.01% | 2127 |
|
|
2018
Q4 | $29.8M | Buy |
477,000
+18,800
| +4% | +$1.31M | 0.01% | 1366 |
|
|
2018
Q3 | $35.4M | Buy |
458,200
+59,800
| +15% | +$4.52M | 0.01% | 1364 |
|
|
2018
Q2 | $28.2M | Sell |
398,400
-57,200
| -13% | -$4.04M | ﹤0.01% | 1542 |
|
|
2018
Q1 | $34.3M | Sell |
455,600
-911,400
| -67% | -$72.5M | 0.01% | 1329 |
|
|
2017
Q4 | $97.9M | Buy |
1,367,000
+246,500
| +22% | +$18.7M | 0.02% | 733 |
|
|
2017
Q3 | $90.8M | Sell |
1,120,500
-110,400
| -9% | -$8.44M | 0.01% | 809 |
|
|
2017
Q2 | $87.1M | Sell |
1,230,900
-1,401,500
| -53% | -$93.3M | 0.02% | 750 |
|
|
2017
Q1 | $179M | Buy |
2,632,400
+1,443,500
| +121% | +$102M | 0.04% | 448 |
|
|
2016
Q4 | $85.1M | Buy |
1,188,900
+416,100
| +54% | +$30.9M | 0.02% | 728 |
|
|
2016
Q3 | $61.1M | Buy |
772,800
+310,000
| +67% | +$25.2M | 0.01% | 861 |
|
|
2016
Q2 | $38.6M | Sell |
462,800
-301,800
| -39% | -$26.8M | 0.01% | 1145 |
|
|
2016
Q1 | $70.2M | Buy |
764,600
+67,200
| +10% | +$6.06M | 0.02% | 766 |
|
|
2015
Q4 | $70.6M | Buy |
697,400
+56,800
| +9% | +$5.91M | 0.02% | 824 |
|
|
2015
Q3 | $62.9M | Sell |
640,600
-44,900
| -7% | -$4.99M | 0.02% | 849 |
|
|
2015
Q2 | $80.3M | Sell |
685,500
-37,100
| -5% | -$4.05M | 0.03% | 655 |
|
|
2015
Q1 | $70.9M | Sell |
722,600
-196,900
| -21% | -$20M | 0.02% | 660 |
|
|
2014
Q4 | $86.7M | Buy |
919,500
+299,300
| +48% | +$31M | 0.03% | 603 |
|
|
2014
Q3 | $66M | Buy |
620,200
+6,600
| +1% | +$646K | 0.02% | 714 |
|
|
2014
Q2 | $50.9M | Buy |
613,600
+116,000
| +23% | +$9.03M | 0.02% | 823 |
|
|
2014
Q1 | $35.3M | Sell |
497,600
-161,600
| -25% | -$12.7M | 0.01% | 934 |
|
|
2013
Q4 | $49.5M | Buy |
659,200
+167,900
| +34% | +$11.7M | 0.02% | 772 |
|
|
2013
Q3 | $30.9M | Sell |
491,300
-572,600
| -54% | -$34.2M | 0.01% | 961 |
|
|
2013
Q2 | $54.5M | Buy |
+1,063,900
| New | +$55.5M | 0.02% | 649 |
|
Other funds holding GILD
VCM
VPM
Bank of America's GILD Position: Q1 2026 in Review
Bank of America reduced its Gilead Sciences (GILD) stake by 14% in Q1 2026, selling an estimated $440M and leaving 19,978,936 shares worth $2.78B. The position accounts for 0.2% of the portfolio, ranked #98.
Bank of America first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.84B in Q4 2025. 2,316 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Bank of America held 19,978,936 shares of Gilead Sciences worth $2.78B as of Q1 2026.
- Bank of America sold 3,142,684 Gilead Sciences shares in Q1 2026, an estimated $440M.
- Gilead Sciences made up 0.2% of Bank of America's portfolio in Q1 2026, its #98 holding.
- Bank of America first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- Bank of America's Gilead Sciences position peaked at $2.84B in Q4 2025.
- 2,316 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.